RecruitingNCT07067983

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening


Sponsor

Zhejiang Cancer Hospital

Enrollment

1,000,000 participants

Start Date

May 30, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing an AI-based screening model called GRAPE that can analyze routine CT scan images to identify patterns that may indicate gastric cancer (stomach cancer) — potentially detecting it earlier than current methods, even when the CT scan was ordered for other reasons. Early detection of stomach cancer significantly improves treatment outcomes. **You may be eligible if...** - You are 18 to 80 years old - You are already scheduled to have a chest or abdominal CT scan for any reason - You are willing to participate and sign a consent form **You may NOT be eligible if...** - You have already been diagnosed with gastric (stomach) cancer - You have severe intellectual disabilities or communication difficulties that prevent you from understanding or participating in the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTResults following systematic screening

The GRAPE model's output (positive or negative) determines whether patients require follow-up gastroscopy


Locations(1)

Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07067983


Related Trials